FindTrial
Sign In

Ultrasound-Guided Biopsy

PROCEDURE3 trials

Sponsors

M.D. Anderson Cancer Center, Mayo Clinic

Conditions

Advanced CholangiocarcinomaAnatomic Stage III Breast Cancer AJCC v8Breast CancerLocally Advanced Breast CarcinomaMetastatic CholangiocarcinomaRefractory CholangiocarcinomaResectable Breast CarcinomaStage III Hilar Cholangiocarcinoma AJCC v8

Phase 1

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
TerminatedNCT06420349
Mayo ClinicAdvanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Refractory Cholangiocarcinoma +4
Start: 2024-05-31End: 2025-09-09Updated: 2025-12-22

Unknown Phase

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery
Active, not recruitingNCT02455791
M.D. Anderson Cancer CenterBreast Cancer
Start: 2015-06-24End: 2026-12-31Updated: 2026-03-09
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer
SuspendedNCT05547347
Mayo ClinicAnatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Resectable Breast Carcinoma
Start: 2023-03-21End: 2026-12-31Target: 15Updated: 2026-03-31

Related Papers

A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinoma
Future Oncology2025-07-282 citations